Skip to main content
. 2020 May 21;245(17):1615–1625. doi: 10.1177/1535370220926938

Table 1.

Potential retinoid therapeutics for AMD-like retinal degeneration.

Compound name Chemical structure Protection mechanism References
C20-D3-vitamin A graphic file with name 10.1177_1535370220926938-img1.jpg • Slowing the rate of all-trans-retinal
dimerization
• Deceleration of A2E biosynthesis
5556
Isotretinoin graphic file with name 10.1177_1535370220926938-img2.jpg • Decrease of 11-cis-retinal levels 5758
N-(4-Hydroxyphenyl)
retinamide
graphic file with name 10.1177_1535370220926938-img3.jpg • Reversible suppression of the visual cycle 59
Emixustat graphic file with name 10.1177_1535370220926938-img4.jpg • Reversible suppression of the visual cycle 6062
Retinylamine graphic file with name 10.1177_1535370220926938-img5.jpg • Reversible suppression of the visual cycle 61
11-cis-6-member-retinal graphic file with name 10.1177_1535370220926938-img6.jpg • Prevention of the retinal isomerization
• Locking the chromophore within the
receptor’s ligand-binding pocket
65